Neuromod portfolios advance at Medtronic, Boston Scientific, Abbott

Abbott Laboratories, Boston Scientific and Medtronic all disclosed neuromodulation updates on Thursday, a flurry of activity that is further evidence of the medtech industry’s attempts to innovate in a sector criticized as stagnant just one year ago